Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$79.4 - $116.36 $243,996 - $357,574
-3,073 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$86.42 - $109.81 $13,049 - $16,581
151 Added 5.17%
3,073 $323,000
Q4 2021

Feb 02, 2022

BUY
$98.56 - $119.91 $11,531 - $14,029
117 Added 4.17%
2,922 $315,000
Q3 2021

Nov 12, 2021

BUY
$91.91 - $110.37 $13,326 - $16,003
145 Added 5.45%
2,805 $307,000
Q2 2021

Jul 23, 2021

BUY
$86.24 - $95.92 $26,475 - $29,447
307 Added 13.05%
2,660 $249,000
Q1 2021

May 06, 2021

BUY
$71.83 - $95.48 $169,015 - $224,664
2,353 New
2,353 $217,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Trust Investment Advisors Portfolio

Follow Trust Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Trust Investment Advisors with notifications on news.